RXRX logo

RXRX
Recursion Pharmaceuticals Inc

14,237
Mkt Cap
$2.17B
Volume
17.11M
52W High
$12.36
52W Low
$3.79
PE Ratio
-2.80
RXRX Fundamentals
Price
$4.88
Prev Close
$5.00
Open
$5.07
50D MA
$5.28
Beta
2.52
Avg. Volume
67.35M
EPS (Annual)
-$1.69
P/B
2.35
Loading...
Loading...
News
all
press releases
Recursion Pharmaceuticals (RXRX) Reports Q3 Loss, Misses Revenue Estimates
Recursion Pharmaceuticals (RXRX) delivered earnings and revenue surprises of +5.26% and -70.34%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3h ago
News Placeholder
More News
News Placeholder
Recursion Pharmaceuticals to Report Q3 Earnings: What's in the Cards?
RXRX gears up for Q3 results as it refocuses its pipeline and collaboration-driven revenue strategy.
Zacks·2d ago
News Placeholder
Earnings Preview: Recursion Pharmaceuticals (RXRX) Q3 Earnings Expected to Decline
Recursion Pharmaceuticals (RXRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·7d ago
News Placeholder
Recursion Pharmaceuticals (RXRX) Stock Declines While Market Improves: Some Information for Investors
In the most recent trading session, Recursion Pharmaceuticals (RXRX) closed at $5.91, indicating a -6.19% shift from the previous trading day.
Zacks·8d ago
News Placeholder
Recursion Pharmaceuticals (RXRX) Dips More Than Broader Market: What You Should Know
In the latest trading session, Recursion Pharmaceuticals (RXRX) closed at $5.75, marking a -5.89% move from the previous day.
Zacks·14d ago
News Placeholder
Recursion Pharmaceuticals (RXRX) Suffers a Larger Drop Than the General Market: Key Insights
Recursion Pharmaceuticals (RXRX) closed the most recent trading day at $6.36, moving 6.33% from the previous trading session.
Zacks·20d ago
News Placeholder
Recursion Pharmaceuticals (RXRX) Dips More Than Broader Market: What You Should Know
The latest trading day saw Recursion Pharmaceuticals (RXRX) settling at $5.23, representing a -5.42% change from its previous close.
Zacks·29d ago
News Placeholder
Recursion Pharmaceuticals (RXRX) Surges 8.2%: Is This an Indication of Further Gains?
Recursion Pharmaceuticals (RXRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks·1mo ago
News Placeholder
Recursion Pharmaceuticals (RXRX) Laps the Stock Market: Here's Why
The latest trading day saw Recursion Pharmaceuticals (RXRX) settling at $4.98, representing a +1.32% change from its previous close.
Zacks·1mo ago
News Placeholder
Recursion Pharmaceuticals (RXRX) Stock Sinks As Market Gains: What You Should Know
Recursion Pharmaceuticals (RXRX) concluded the recent trading session at $4.77, signifying a -1.24% move from its prior day's close.
Zacks·2mo ago

Latest RXRX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.